Market Cap 62.99M
Revenue (ttm) 3.95M
Net Income (ttm) -131.21M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,321.77%
Debt to Equity Ratio 0.00
Volume 86,900
Avg Vol 68,912
Day's Range N/A - N/A
Shares Out 6.15M
Stochastic %K 47%
Beta 2.77
Analysts Strong Sell
Price Target $95.00

Company Profile

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of non-alcoholic steatohepatitis (NASH). The company also develops ALG-000184, a capsid assembly modulator, which is completed Phase 1b clinical trial to treat chronic hepatitis B (CHB); and ALG-12575...

Industry: Biotechnology
Sector: Healthcare
Phone: 800-466-6059
Address:
One Corporate Drive, 2nd Floor, South San Francisco, United States
Cajo0404
Cajo0404 Sep. 30 at 9:41 PM
$ALGS Check back in 5 years. There will be no news and a sleeping PR team still.
0 · Reply
Buyhighsellatlow
Buyhighsellatlow Sep. 26 at 7:30 PM
$ALGS I’ll take $615/share. Heck, I’d take $163/share. It’s a long play but don’t sleep on this one. News will move it.
0 · Reply
Cajo0404
Cajo0404 Sep. 26 at 2:27 PM
$ALGS If they found the cure for cancer they wouldn’t take the time to. Put out a news article. This PR team is worthless.
0 · Reply
Cajo0404
Cajo0404 Sep. 25 at 7:05 PM
$ALGS Bulls and bears Agee are on one thing here. No news is coming because the PR team has no idea what marketing means.
1 · Reply
TheArtOfFinancialWar
TheArtOfFinancialWar Sep. 25 at 12:09 AM
$ALGS no 33 of 100 speculations in 2026 that will outperform $SPY. (I'm not an expert in bio stocks, but this one has a very good setup, fundamentals, and the hexagram is a "yes"). @mhparvez @LabPsycho @bsnacks @blancoBull @sonicmerlin
0 · Reply
RollTheDice168
RollTheDice168 Sep. 24 at 6:17 PM
$ALGS DCAing on this quarterly, for the next 2 to 3 years. GLTA!
0 · Reply
Quantumup
Quantumup Sep. 24 at 5:14 PM
UBS reiterated $MDGL at Buy-$523-High Conviction Call and said, we think mgmt sounds upbeat on #MASH market dynamics, highlights durable large opportunity in the growing MASH market Reiterate high conviction call in $MDGL as a commercial biotech story where we still see significant upside potential to valuation on Rezdiffra launch trajectory in the near & long-term ... We think mgmt continues to sound upbeat on Rezdiffra's profile, the launch, and the long-term opportunity. Notably, we think mgmt sounds confident in continued patient demand amidst the launch of sema & upbeat on conversations with payors. $NVO $IVA $VKTX $ALGS
0 · Reply
TheArtOfFinancialWar
TheArtOfFinancialWar Sep. 24 at 2:59 PM
$QURE bio stocks are so hard to play. I'm not an expert in bio stocks. However, someone gave me a tip about $GILD last year. Now that person also gave me a tip about $ALGS, but my weakness is bio stock. @LabPsycho @mhparvez @blancoBull
1 · Reply
HedgeUrHedge
HedgeUrHedge Sep. 24 at 1:34 PM
$ALGS thank you for your attention to this matter. This will be my last post on Aligos and hope for y'all to be prosperous in the upcoming years to come with my DD.
0 · Reply
HedgeUrHedge
HedgeUrHedge Sep. 24 at 1:31 PM
$ALGS im going to call out exactly what is going to happen ahead of time so these bad actors try not to pull some shit on retail investors. If Aligos makes a successful drug, we will see random short and distort articles come out or random and most likely fake anonymous whistleblowers come out the wood works saying the drug is bad or trial was not as good as expected for the intent to significantly drop the stock. Its not a matter of "if", but "when" so ignore any allegations until actual FACTS come out from the company itself, if these bad actors pull that type of shit. I don't know what they will come up with, but they are very good at insinuating that on a thin line of facts leaning more towards assumptions.
0 · Reply
Latest News on ALGS
Aligos Therapeutics Presents Positive Data at APASL 2025

Mar 26, 2025, 8:00 AM EDT - 6 months ago

Aligos Therapeutics Presents Positive Data at APASL 2025


Aligos Therapeutics Announces Reverse Stock Split

Aug 15, 2024, 9:00 AM EDT - 1 year ago

Aligos Therapeutics Announces Reverse Stock Split


Cajo0404
Cajo0404 Sep. 30 at 9:41 PM
$ALGS Check back in 5 years. There will be no news and a sleeping PR team still.
0 · Reply
Buyhighsellatlow
Buyhighsellatlow Sep. 26 at 7:30 PM
$ALGS I’ll take $615/share. Heck, I’d take $163/share. It’s a long play but don’t sleep on this one. News will move it.
0 · Reply
Cajo0404
Cajo0404 Sep. 26 at 2:27 PM
$ALGS If they found the cure for cancer they wouldn’t take the time to. Put out a news article. This PR team is worthless.
0 · Reply
Cajo0404
Cajo0404 Sep. 25 at 7:05 PM
$ALGS Bulls and bears Agee are on one thing here. No news is coming because the PR team has no idea what marketing means.
1 · Reply
TheArtOfFinancialWar
TheArtOfFinancialWar Sep. 25 at 12:09 AM
$ALGS no 33 of 100 speculations in 2026 that will outperform $SPY. (I'm not an expert in bio stocks, but this one has a very good setup, fundamentals, and the hexagram is a "yes"). @mhparvez @LabPsycho @bsnacks @blancoBull @sonicmerlin
0 · Reply
RollTheDice168
RollTheDice168 Sep. 24 at 6:17 PM
$ALGS DCAing on this quarterly, for the next 2 to 3 years. GLTA!
0 · Reply
Quantumup
Quantumup Sep. 24 at 5:14 PM
UBS reiterated $MDGL at Buy-$523-High Conviction Call and said, we think mgmt sounds upbeat on #MASH market dynamics, highlights durable large opportunity in the growing MASH market Reiterate high conviction call in $MDGL as a commercial biotech story where we still see significant upside potential to valuation on Rezdiffra launch trajectory in the near & long-term ... We think mgmt continues to sound upbeat on Rezdiffra's profile, the launch, and the long-term opportunity. Notably, we think mgmt sounds confident in continued patient demand amidst the launch of sema & upbeat on conversations with payors. $NVO $IVA $VKTX $ALGS
0 · Reply
TheArtOfFinancialWar
TheArtOfFinancialWar Sep. 24 at 2:59 PM
$QURE bio stocks are so hard to play. I'm not an expert in bio stocks. However, someone gave me a tip about $GILD last year. Now that person also gave me a tip about $ALGS, but my weakness is bio stock. @LabPsycho @mhparvez @blancoBull
1 · Reply
HedgeUrHedge
HedgeUrHedge Sep. 24 at 1:34 PM
$ALGS thank you for your attention to this matter. This will be my last post on Aligos and hope for y'all to be prosperous in the upcoming years to come with my DD.
0 · Reply
HedgeUrHedge
HedgeUrHedge Sep. 24 at 1:31 PM
$ALGS im going to call out exactly what is going to happen ahead of time so these bad actors try not to pull some shit on retail investors. If Aligos makes a successful drug, we will see random short and distort articles come out or random and most likely fake anonymous whistleblowers come out the wood works saying the drug is bad or trial was not as good as expected for the intent to significantly drop the stock. Its not a matter of "if", but "when" so ignore any allegations until actual FACTS come out from the company itself, if these bad actors pull that type of shit. I don't know what they will come up with, but they are very good at insinuating that on a thin line of facts leaning more towards assumptions.
0 · Reply
Paddy444
Paddy444 Sep. 24 at 10:16 AM
$ALGS This cute one is just getting prim and proper for quite the November in my what feels like a shaky morning.. hands wise Mind wise, well no mistakes there, no misjudgments, just results that are solid and consistent, I'm grateful Work right and play some peek a boo here going into late Sept or perhaps earlier for your tickle trunk 444
0 · Reply
RollTheDice168
RollTheDice168 Sep. 23 at 4:38 PM
$ALGS This reminds me of Harvoni. Looks like we'll be finding out in a couple of years.
0 · Reply
aletz
aletz Sep. 23 at 3:16 PM
$ALGS https://www.reddit.com/r/pennystocks/comments/1nojpjx/algs_over_5000_potential_with_bestinclass_hbv/ My comprehensive DD on Aligos
1 · Reply
Cajo0404
Cajo0404 Sep. 23 at 2:51 PM
$ALGS If you ever see this green which is rare it’s a clear signal to short this garbage. You don’t have to worry about PR or good news hardly ever here.
0 · Reply
Buyhighsellatlow
Buyhighsellatlow Sep. 23 at 1:36 PM
$ALGS broke above the 30 week SMA and is now pulling back to the 50 day for only the second time. Could be an interesting spot.
0 · Reply
Bwnuts
Bwnuts Sep. 19 at 8:49 PM
$ALGS https://www.pharmexec.com/view/lawrence-blatt-taking-leap-scientist-founder
0 · Reply
Cajo0404
Cajo0404 Sep. 19 at 8:32 PM
$ALGS Only down 76% on the year is a huge win for this company.
0 · Reply
Cajo0404
Cajo0404 Sep. 19 at 7:41 PM
$ALGS What do you think the PR team does all day? They don’t have a clue. Easy short with no news ever.
0 · Reply
aletz
aletz Sep. 18 at 8:13 PM
$ALGS Analyst price targets in the vicinity of $50 appear a total joke, as they would imply a market capitalization of $250 million. A more realistic valuation would be a minimum of $2 billion. November data is going to be extremely exciting.
2 · Reply
Bwnuts
Bwnuts Sep. 18 at 2:46 PM
$ALGS space is heating up. https://www.reuters.com/business/healthcare-pharmaceuticals/roche-acquire-liver-drug-developer-89bio-up-35-billion-2025-09-18/
0 · Reply
IPOARMY1
IPOARMY1 Sep. 18 at 8:05 AM
$ETNB $ALGS YOU'RE NEXT!!!
1 · Reply
GMExAPE
GMExAPE Sep. 17 at 9:34 PM
RMFC stock has 5X potential, shorts at zero borrow and the 3m float is locked. Very undervalued here. Historic short squeeze coming - No dilution - Catalysts coming - Just reported record financials and added a new store a few weeks ago. $RVSB $ALGS $EDAP $SIEB $SHIB.X hmmm
0 · Reply